| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
A Case of Familial Hypoalphalipoproteinemia with Significant Premature Atherosclerosis
|
Rahman, Tahmid
|
|
|
18 |
4S |
p. e505-e506
|
article
|
| 2 |
Accelerated Atherosclerosis in a Patient With Multifactorial Chylomicronemia Syndrome (MCS), Elevated Lp(a), APOE2/4 Genotype and Diabetes Mellitus.
|
Roth, Mendel
|
|
|
18 |
4S |
p. e538
|
article
|
| 3 |
*Achievement of Low-Density Lipoprotein Cholesterol (LDL-C) Thresholds in Patients with Very High-Risk Atherosclerotic Cardiovascular Disease (ASCVD)
|
Saseen, Joseph
|
|
|
18 |
4S |
p. e550-e551
|
article
|
| 4 |
A Controlled Intervention Restricting AGEs Improves Carboxymethyl Lysine, RAGE, Lipid, and Inflammatory Indices in Patients Undergoing Hemodialysis
|
Aroni, Adamantia
|
|
|
18 |
4S |
p. e548
|
article
|
| 5 |
A Father's Last Message: The Value of Polygenic Risk Scoring in Familial CAD
|
Soffer, Daniel
|
|
|
18 |
4S |
p. e503-e504
|
article
|
| 6 |
†Age- and Sex-Specific Nomographic CT Quantitative Plaque Data From a Large International Cohort
|
Tzimas, George
|
|
|
18 |
4S |
p. e578-e579
|
article
|
| 7 |
A Novel Nanoparticle Lipoprotein Free Cholesterol Mass Transfer Assay
|
Neufeld, Edward
|
|
|
18 |
4S |
p. e580-e581
|
article
|
| 8 |
A Patient who is Nonresponsive to PSCK9 Inhibition by both mAb and RNAi
|
Gianos, Eugenia
|
|
|
18 |
4S |
p. e507
|
article
|
| 9 |
†A Pilot Study of Triglyceride Screening in Blood Donors
|
Eason, Stephen
|
|
|
18 |
4S |
p. e532
|
article
|
| 10 |
Apo E Genotyping and Cardiovascular Risk Re-Classification of Subjects, A Single Center Experience 2008-2022
|
Shaish, Aviv
|
|
|
18 |
4S |
p. e485-e486
|
article
|
| 11 |
A Rare Encounter: Familial Lipoprotein Lipase Deficiency in Pregnancy - Case Review and Emerging Therapies for Familial Chylomicronemia Syndrome
|
Rajpal, Aman
|
|
|
18 |
4S |
p. e502
|
article
|
| 12 |
ASCVD Risk Reduction in Patients with Immune-Mediated Inflammatory Disease: A Retrospective Quality Assessment Study
|
Monzer, Nasser
|
|
|
18 |
4S |
p. e510-e511
|
article
|
| 13 |
ASCVD Risk Stratification in a Large Urban Clinic – Role of CACS in Reclassifying Black versus White Individuals Seen for Preventive Care.
|
Peters, Matthew
|
|
|
18 |
4S |
p. e512-e513
|
article
|
| 14 |
†Assessment of Unmet Clinical Needs and Healthcare Resource Use among Statin-Treated Patients with or at Risk of Developing ASCVD
|
Rambo, Bob
|
|
|
18 |
4S |
p. e519-e520
|
article
|
| 15 |
Association Between Niacin-ER Use, Safety, and Cardiovascular Events. A Single Center Experience.
|
Caraang, Chris
|
|
|
18 |
4S |
p. e554-e555
|
article
|
| 16 |
Atlantic Lipid Lowering Treatment Optimization Program (ALLTOP): A Comprehensive Approach to the Treatment of Familial Hypercholesterolemia and Comple
|
Proute, Matthew
|
|
|
18 |
4S |
p. e493-e494
|
article
|
| 17 |
Atrial Fibrillation Outcome in Patients with Metabolic Syndrome.
|
Somoza-Cano, Francisco
|
|
|
18 |
4S |
p. e556
|
article
|
| 18 |
Attitudes and Barriers to Lipoprotein(a) Testing: A Survey of Providers at the University of Pennsylvania Health System
|
Bajaj, Archna
|
|
|
18 |
4S |
p. e487-e488
|
article
|
| 19 |
*Calculated Small Dense LDL-C has a Stronger Association to Atherosclerotic Cardiovascular Events than other Components of the Lipid Panel.
|
Sampson, Maureen
|
|
|
18 |
4S |
p. e499-e500
|
article
|
| 20 |
Cardiovascular Outcomes Unveiled: Bempedoic Acid in Hyperlipidemia—A Comprehensive Updated Systematic Review and Meta-analysis of RCTs
|
Ali, Saba
|
|
|
18 |
4S |
p. e570-e571
|
article
|
| 21 |
†Cardiovascular Trials Over the Last 15 years: Analysis of the Characteristics and Trends of ClinicalTrials.gov Listings from 2008 to 2022
|
Allaham, Laith
|
|
|
18 |
4S |
p. e549-e550
|
article
|
| 22 |
Centralized Cascade Screening for Familial Hypercholesterolemia: Perspectives of Patients and Providers
|
Brown, Ashley
|
|
|
18 |
4S |
p. e544-e545
|
article
|
| 23 |
Clinical Outcomes And Mortality in Heart Failure And Chronic Kidney Disease Patients Admitted With Non-Variceal Upper Gastrointestinal Bleeding
|
Hijazi, Mohamad
|
|
|
18 |
4S |
p. e520
|
article
|
| 24 |
Clinical Outcomes in Patients Admitted with Acute Coronary Syndrome Affected by Protein Calorie Malnutrition.
|
Rahima, Kenan
|
|
|
18 |
4S |
p. e528
|
article
|
| 25 |
Clinical Outcomes in Patients admitted with Diabetes Mellitus and Chronic Kidney Disease Affected by Non-Alcoholic Fatty Liver Disease
|
Hijazi, Mohamad
|
|
|
18 |
4S |
p. e529-e530
|
article
|
| 26 |
Comparative Assessment of hsCRP and Apolipoprotein B as ASCVD Risk Biomarkers
|
Amusat, Saheed
|
|
|
18 |
4S |
p. e499
|
article
|
| 27 |
Comparison of Package Insert versus Real World Safety Data from Branded Icosapent Ethyl Users: A Select Analysis Utilizing MarketScan Data
|
Nelson, John
|
|
|
18 |
4S |
p. e574
|
article
|
| 28 |
Coronary Artery Disease in Familial Hypoalphalipoproteinemia: A Case Report
|
Moussa, Sumer
|
|
|
18 |
4S |
p. e504
|
article
|
| 29 |
Detailed Family History of Premature Atherosclerotic Cardiovascular Disease to Guide Lipoprotein(a) Testing: The Multi-Ethnic Study of Atherosclerosis
|
Bhatia, Harpreet
|
|
|
18 |
4S |
p. e486-e487
|
article
|
| 30 |
Development of a Clinical Diagnostic Score for Familial Chylomicronemia Syndrome (FCS)
|
Campos, Cynthia
|
|
|
18 |
4S |
p. e536
|
article
|
| 31 |
Development of the Family Heart Foundation™ Flag, Identify, Network, Deliver—Familial Hypercholesterolemia (FIND-FH™) Implementation Toolkit
|
MacDougall, Diane
|
|
|
18 |
4S |
p. e495-e496
|
article
|
| 32 |
Differences in Clinical Outcomes between Non-Obese African American and Asian Populations Who have Hyperlipidemia
|
Khokhlov, Leonid
|
|
|
18 |
4S |
p. e558-e559
|
article
|
| 33 |
Differences in Clinical Outcomes between Non-Obese Caucasian and Asian Populations Who have Hyperlipidemia
|
Khokhlov, Leonid
|
|
|
18 |
4S |
p. e558
|
article
|
| 34 |
+Differences in Clinical Outcomes between Non-Obese Caucasian and Hispanic Populations Who have Hyperlipidemia
|
Khokhlov, Leonid
|
|
|
18 |
4S |
p. e557
|
article
|
| 35 |
Differences in Clinical Outcomes Between Non-Obese Caucasians and African American Populations with Hyperlipidemia
|
Khokhlov, Leonid
|
|
|
18 |
4S |
p. e576-e577
|
article
|
| 36 |
Differences in Clinical outcomes between Non-Obese Hispanic and Asian populations Who have Hyperlipidemia
|
Khokhlov, Leonid
|
|
|
18 |
4S |
p. e559-e560
|
article
|
| 37 |
Discrepancies in Prescribing Practices for SGLT2 Inhibitors Between Sexes
|
Rege, Rahul
|
|
|
18 |
4S |
p. e515
|
article
|
| 38 |
Effect of Diabetes Mellitus (T2DM) Medications on Lipid Parameters in Veterans with T2DM and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD)
|
Ubalde, Shannen Nicole
|
|
|
18 |
4S |
p. e493
|
article
|
| 39 |
Elevated Levels of Lp(a) are Associated with Circulating Levels of PCSK9 and Coronary Atherosclerosis as Detected by Cardiac Computed Tomography Angiography
|
Brown, Bradley
|
|
|
18 |
4S |
p. e577-e578
|
article
|
| 40 |
Elevated Serum Small Dense Low Density Lipoprotein Cholesterol and Lipoprotein(a) Levels in Preeclampsia
|
Wolfe, Elizabeth
|
|
|
18 |
4S |
p. e498-e499
|
article
|
| 41 |
†Evaluation of Chenodeoxycholic Acid Treatment in Adult Patients with Cerebrotendinous Xanthomatosis: A Randomized, Placebo-Controlled Phase 3 Study
|
DeBarber, Andrea
|
|
|
18 |
4S |
p. e540-e541
|
article
|
| 42 |
Exploring the Impact of Gender and BMI on Apolipoprotein B in Adult Subjects
|
Amusat, Saheed
|
|
|
18 |
4S |
p. e518-e519
|
article
|
| 43 |
FADS2 Indel Polymorphism rs66698963 Predicts Colorectal Polyp Prevention by the n-3 Fatty Acid EPA
|
Block, Robert
|
|
|
18 |
4S |
p. e535-e536
|
article
|
| 44 |
Familial Hypercholesterolemia: Can Continuing Medical Education Help Address Barriers to Screening in Children?
|
Morris, Pamela
|
|
|
18 |
4S |
p. e537-e538
|
article
|
| 45 |
Familial Hypercholesterolemia Cascade: On the Road to Universal Screening
|
Proute, Matthew
|
|
|
18 |
4S |
p. e542-e543
|
article
|
| 46 |
Familial Hypercholesterolemia Diagnosis and Management: Insights from the NIH Precision Medicine Initiative All of Us Study
|
Block, Robert
|
|
|
18 |
4S |
p. e539
|
article
|
| 47 |
Fellow Quality Improvement Project: Identification of High Risk CAD Patients and Referral to Newly Established Lipid Clinic, What are the Clinical Implications?
|
Rinehart, Sarah
|
|
|
18 |
4S |
p. e581-e582
|
article
|
| 48 |
Fenofibric Acid has Distinct Molecular Location in Reconstituted Liver Membranes and Higher Affinity Compared to Pemafibrate
|
Sherratt, Samuel
|
|
|
18 |
4S |
p. e573-e574
|
article
|
| 49 |
†Food Compass Score is Inversely Related to Inflammatory Markers and Cardiovascular Disease Incidence: Results from the ATTICA Cohort Study (2002-2022)
|
Damigou, Evangelia
|
|
|
18 |
4S |
p. e529
|
article
|
| 50 |
Genetic Testing Results in a Preventative Cardiology and Inherited Lipid Disorders Clinic
|
Elysee, Isaac
|
|
|
18 |
4S |
p. e540
|
article
|
| 51 |
Health Outcomes and Survival of Patients with Severe Hypertriglyceridemia after Acute Pancreatitis
|
Chang, Eunice
|
|
|
18 |
4S |
p. e486
|
article
|
| 52 |
†High Rates of Cardiovascular Events in Patients with Multivessel Disease in the First Year Post-Myocardial Infarction: A Systematic Literature Review
|
Korjian, Serge
|
|
|
18 |
4S |
p. e518
|
article
|
| 53 |
Impact of Familial Hypercholesterolemia on Coronary Artery Dissection in Patients Undergoing Percutaneous Coronary Intervention (PCI)
|
Yang, Chris
|
|
|
18 |
4S |
p. e534-e535
|
article
|
| 54 |
+Impact of Grant-Funded Coronary Artery Calcium Score on Cardiovascular Risk Assessment and Management in an Underserved Population
|
Ambrosino, Maxwell
|
|
|
18 |
4S |
p. e511-e512
|
article
|
| 55 |
Impact of Non-Alcoholic Fatty Liver Disease on Heart Failure Hospitalizations: Insights from the National Inpatient Sample Database
|
Yang, Chris
|
|
|
18 |
4S |
p. e534
|
article
|
| 56 |
^Improving Risk Stratification in Severe Hypercholesterolemia: Provider Recommendations for Developing a Program to Communicate ASCVD Risk
|
Salvati, Zachary
|
|
|
18 |
4S |
p. e508-e509
|
article
|
| 57 |
†Interaction of AI-Enabled Quantitative Coronary Plaque Analysis Volumes on Coronary CT Angiography, FFRCT, and Clinical Outcomes: A Retrospective Analysis of the ADVANCE Registry
|
Huey, Whitney
|
|
|
18 |
4S |
p. e579-e580
|
article
|
| 58 |
Lipid lowering Injectable Clinic-Novel Idea for Improving Compliance with Twice Yearly Dosing of Inclisiran
|
Ali, Ahmad
|
|
|
18 |
4S |
p. e495
|
article
|
| 59 |
Lipoprotein (a) Discovery Project: Initiative to Identify Awareness and Models of Lipoprotein (a) Testing for National Education
|
Pena, David
|
|
|
18 |
4S |
p. e489-e490
|
article
|
| 60 |
Lipoprotein(a)’s Prediction of Cardiovascular Disease Events When Accessed via Electronic Health Records
|
Block, Robert C
|
|
|
18 |
4S |
p. e555
|
article
|
| 61 |
Lomitapide in Pediatric Patients with Homozygous Familial Hypercholesterolemia – Analysis of Secondary and Safety Endpoints from the APH-19 Study
|
Schmitt, Claus
|
|
|
18 |
4S |
p. e545-e546
|
article
|
| 62 |
Lower Activity of Cholesteryl Ester Transfer protein (CETP) and the Risk of Dementia: A Mendelian Randomization Analysis
|
Hsieh, Andrew K
|
|
|
18 |
4S |
p. e577
|
article
|
| 63 |
Multidisciplinary Management of Lipoprotein X-Induced Hyperlipidemia Secondary to Drug-Induced Liver Injury
|
Kim, Samuel
|
|
|
18 |
4S |
p. e502-e503
|
article
|
| 64 |
Negative LDL-C levels with Detectable Apolipoprotein B: Surrogate Markers of Atherosclerotic Disease and Cardiac Event Risk
|
Haynes, Tiffany
|
|
|
18 |
4S |
p. e501-e502
|
article
|
| 65 |
†Not Published
|
|
|
|
18 |
4S |
p. e550
|
article
|
| 66 |
Obicetrapib Alone and with Ezetimibe Reduces Non-HDL-C by Enhanced LDL-Receptor-Mediated VLDL Clearance and Increased Net Fecal Sterol Excretion
|
Keijzer, Nanda
|
|
|
18 |
4S |
p. e552
|
article
|
| 67 |
†Obicetrapib Demonstrates Significant Reductions Of Lp(a) On Top Of High-intensity Statins
|
Hsieh, Andrew
|
|
|
18 |
4S |
p. e563-e564
|
article
|
| 68 |
†Obicetrapib Does Not Accumulate in Adipose Tissue: Results from Studies in Man and Non-human Primates
|
Hsieh, Andrew
|
|
|
18 |
4S |
p. e563
|
article
|
| 69 |
†Obicetrapib Treatment Increases Pre-Beta1 HDL and Lipophilic Antioxidants in the Ocean and Rose2 Studies
|
Ditmarsch, Marc
|
|
|
18 |
4S |
p. e566-e567
|
article
|
| 70 |
Oleocanthal-Rich Olive Oil's Effect on Postprandial Platelet Activity and Oxidative Stress Markers of Type 2 Diabetic Patients
|
Detopoulou, Paraskevi
|
|
|
18 |
4S |
p. e576
|
article
|
| 71 |
Optimizing Residual Cardiovascular Risk in a Case of Homozygous Familial Hypercholesterolemia (HoFH) and Elevated Lipoprotein (a) [Lp(a)]
|
Hasham, Salman
|
|
|
18 |
4S |
p. e539-e540
|
article
|
| 72 |
Pancreatitis Polygenic Risk Score is Associated with Acute Pancreatitis in Multifactorial Chylomicronemia Syndrome
|
Paquette, Martine
|
|
|
18 |
4S |
p. e537
|
article
|
| 73 |
Patient Experience with Familial Chylomicronemia Syndrome before and after Olezarsen Treatment: Qualitative Interviews with Clinical Trial Participants
|
Brown, T. Michelle
|
|
|
18 |
4S |
p. e568-e569
|
article
|
| 74 |
Patients Admitted with Acute pancreatitis and Dyslipidemia Affected by Non-Alcoholic Fatty Liver Disease are Associated with Worse Clinical Outcomes
|
Hijazi, Mohamad
|
|
|
18 |
4S |
p. e532-e533
|
article
|
| 75 |
†Patients Perceive a Considerable Treatment Burden in the First Year after a Myocardial Infarction: Results from an Online US Patient Survey
|
Korjian, Serge
|
|
|
18 |
4S |
p. e550
|
article
|
| 76 |
*Pericardial and Pleural Effusions after Evolocumab in a Patient with Severe Familial Hypercholesterolemia
|
Pavlovic, Maia
|
|
|
18 |
4S |
p. e506-e507
|
article
|
| 77 |
†Pharmacological Trials for the Treatment or Prevention of Coronary Artery Disease: Analysis of ClinicalTrials.gov Listings from 2008 to 2022
|
Bahit, M. Cecilia
|
|
|
18 |
4S |
p. e548-e549
|
article
|
| 78 |
†Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Deep and Durable TG Reductions in Patients With SHTG, SHASTA-2 Final Results
|
Pall, Denes
|
|
|
18 |
4S |
p. e564
|
article
|
| 79 |
†Plozasiran (ARO-APOC3), an Investigational RNAi, Demonstrates Robust and Durable TG Reductions in Patients with Mixed Dyslipidemia, MUIR Final Results
|
Vasas, Szilard
|
|
|
18 |
4S |
p. e560
|
article
|
| 80 |
Population Analysis of Patients at a Multidisciplinary Prevention Center: Insights, Gaps, and Opportunities
|
Burkle, Jaime
|
|
|
18 |
4S |
p. e490-e491
|
article
|
| 81 |
Potential of High Sensitivity C-Reactive Protein in Early Assessment of ASCVD Risk among Prediabetic Patients
|
Amusat, Saheed
|
|
|
18 |
4S |
p. e497
|
article
|
| 82 |
Process Mapping the Lipid Management Patient Pathway in Six Health Systems for Identification of Barriers to Guideline-Directed Care
|
Overton, Katherine
|
|
|
18 |
4S |
p. e488
|
article
|
| 83 |
Protein Calorie Malnutrition Effect on Clinical Outcomes And Resource Utilization in Patients Admitted with Acute Pancreatitis And Dyslipidemia
|
Hijazi, Mohamad
|
|
|
18 |
4S |
p. e533-e534
|
article
|
| 84 |
+Racial Inequities in Coronary Artery Calcium Screening and Follow-up
|
Umer, Muhammad
|
|
|
18 |
4S |
p. e513-e514
|
article
|
| 85 |
Racial Variations in SGLT2 Inhibitor Prescriptions
|
Leung, Christian
|
|
|
18 |
4S |
p. e514-e515
|
article
|
| 86 |
Rates of Lipid Testing among Patients with Atherosclerotic Cardiovascular Disease within a Large Community-Based Health System
|
Li, Hsin-Fang
|
|
|
18 |
4S |
p. e492
|
article
|
| 87 |
†Real-World Effectiveness and Safety of Evinacumab in Patients with Homozygous Familial Hypercholesterolemia: A Multi-site US Perspective
|
Bijlani, Priyesha
|
|
|
18 |
4S |
p. e567-e568
|
article
|
| 88 |
Real-World Evaluation of Lipid Testing Rate and Treatment Target Attainment Among High-Risk Patients: Post Release of the 2018 AHA/ACC Practice Guidelines
|
Visaria, Jay
|
|
|
18 |
4S |
p. e494-e495
|
article
|
| 89 |
Real-world Experience of Inclisiran at the University of Pennsylvania Health Systems
|
Risman, Marjorie
|
|
|
18 |
4S |
p. e491-e492
|
article
|
| 90 |
*Real-World Experience with Inclisiran at a Large Academic Lipid Clinic
|
Wilkinson, Michael
|
|
|
18 |
4S |
p. e553-e554
|
article
|
| 91 |
Real World Experience with Inclisiran in an Academic Medical Center
|
Bartsch, Kelly
|
|
|
18 |
4S |
p. e551-e552
|
article
|
| 92 |
Rethinking Prevention: Need for earlier intervention in Familial Hypercholesteremia despite Statin and PCSK9 Inhibitor Therapy
|
Proute, Matthew
|
|
|
18 |
4S |
p. e543
|
article
|
| 93 |
Role and Expression of 15-Prostaglandin Dehydrogenase in Cartilage tissue
|
Alsabri, Sami
|
|
|
18 |
4S |
p. e572-e573
|
article
|
| 94 |
†Role of DNA methylation on 15-Lipoxygenase-1 gene expression in Osteoarthritis
|
Alsabri, Sami
|
|
|
18 |
4S |
p. e571-e572
|
article
|
| 95 |
†Role of Epigenetic Regulation and Sp1 Rranscription Factor on DP1 Receptor Expression in Osteoarthritis
|
Alsabri, Sami
|
|
|
18 |
4S |
p. e572
|
article
|
| 96 |
Severe Medication Induced Dyslipidemia in an Adult with Breast Cancer
|
Sheth, Sohum
|
|
|
18 |
4S |
p. e555-e556
|
article
|
| 97 |
Study Design of a Phase 3 Randomized Controlled Trial Evaluating the Efficacy and Safety of Pegozafermin in Patients with Severe Hypertriglyceridemia
|
Hartsfield, Cynthia
|
|
|
18 |
4S |
p. e552-e553
|
article
|
| 98 |
†Synergistic Effect of Obicetrapib and Ezetimibe on Circulating LDL Particles
|
Hsieh, Andrew
|
|
|
18 |
4S |
p. e566
|
article
|
| 99 |
Tailored Therapeutic Strategies for the Management of Chylomicronemia Syndrome
|
Skariah, Annie
|
|
|
18 |
4S |
p. e504-e505
|
article
|
| 100 |
The Advancing Cardiac Care Unit-based Rapid Assessment and Treatment of hypErcholesterolemia (ACCURATE) Study – Phase 1 Results
|
Iatan, Iulia
|
|
|
18 |
4S |
p. e546-e547
|
article
|
| 101 |
The Exception that Proves the Rule: Acute Myocardial Infarction in a Person at Extremely Low Risk for Plague Rupture
|
Proute, Matthew
|
|
|
18 |
4S |
p. e501
|
article
|
| 102 |
The Family Heart Foundation™ Flag, Identify, Network, Deliver—Familial Hypercholesterolemia (FIND-FH™) Program and Collaborative Learning Network (CL
|
MacDougall, Diane
|
|
|
18 |
4S |
p. e496-e497
|
article
|
| 103 |
The Food Compass Score is Negatively Related to the Activity of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Healthy Adults.
|
Fragopoulou, Elizabeth
|
|
|
18 |
4S |
p. e573
|
article
|
| 104 |
The IMPACT of Virtual Reality and Other Immersive Tools to Improve the Multidisciplinary Team's Ability to Screen, Diagnose, and Manage FH
|
Allen, Russie
|
|
|
18 |
4S |
p. e489
|
article
|
| 105 |
The Lomitapide Observational Worldwide Evaluation Registry (LOWER) - Nine-year Effectiveness and Safety Data in HoFH
|
Underberg, James
|
|
|
18 |
4S |
p. e545
|
article
|
| 106 |
The Long-Term Efficacy and Safety of Evinacumab in Pediatric Patients with Homozygous Familial Hypercholesterolemia
|
Greber-Platzer, Susanne
|
|
|
18 |
4S |
p. e554
|
article
|
| 107 |
The Outcome of Coronary Artery Bypass Graft in Patient with Prediabetes.
|
Smith, Brittany
|
|
|
18 |
4S |
p. e557-e558
|
article
|
| 108 |
†The Role of Structured Inpatient Lipid Protocols in Optimizing Non-Statin Lipid Lowering Therapy: A Review and Single-Center Experience
|
Gier, Chad
|
|
|
18 |
4S |
p. e516-e518
|
article
|
| 109 |
The Value of Lipid Testing in Recognizing Residual Risk
|
Zias, Ariadne
|
|
|
18 |
4S |
p. e510
|
article
|
| 110 |
Treatment Patterns Among Early Inclisiran vs Anti–PCSK9 mAbs Users: A Retrospective Analysis of US Claims Databases
|
Popadic, Lyuba
|
|
|
18 |
4S |
p. e515-e516
|
article
|
| 111 |
Trends in Age-Adjusted Cardiovascular Mortality Rates with Hyperlipidemia among the United States Population, from 1999–2023: A CDC Wonder Database Study
|
Brands, Chad
|
|
|
18 |
4S |
p. e530-e532
|
article
|
| 112 |
Trends of Global Disease Burden Attributable to Diet low in Polyunsaturated fatty Acidsl From 1990 to 2019: A Global Burden of Disease Study Analysis
|
Abu-Haniyeh, Ahmed
|
|
|
18 |
4S |
p. e520-e521
|
article
|
| 113 |
Unexpected High Cardiovascular Risk in a Healthy Young Patient
|
Jacoby, Douglas
|
|
|
18 |
4S |
p. e507-e508
|
article
|
| 114 |
Unique Case of Familial Hypobetalipoproteinemia (FHBL)
|
Soffer, Daniel
|
|
|
18 |
4S |
p. e543-e544
|
article
|
| 115 |
Unmasking the Silent Culprit: Lipoprotein(a) Elevation in a Previously Healthy Individual
|
Arrigo, Alexis
|
|
|
18 |
4S |
p. e506
|
article
|
| 116 |
†Utility of AI-QCPA: Results of the Decisions for Treating Coronary Disease are Changed in Patients Evaluated with Quantified Plaque Analysis
|
Blankstein, Ron
|
|
|
18 |
4S |
p. e581
|
article
|
| 117 |
Utilizing hsCRP as a Diagnostic Tool for Managing ASCVD: Exploring its Relationships with Cardiometabolic Risk Factors
|
Amusat, Saheed O
|
|
|
18 |
4S |
p. e498
|
article
|
| 118 |
Xanthelasma Associated with Defective Reverse Cholesterol Transport, Resolution with Rosuvastatin/Ezetimibe: A Case Report
|
Doyle, Michael
|
|
|
18 |
4S |
p. e541-e542
|
article
|
Journal description